FerrareseCRivaRDolaraADe MicheliAFrattolaL. Elevated glutamate in the cerebrospinal fluid of patients with HIV dementia (letter). JAMA1997;277:630.
2.
LiptonSAGendelmanHE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med1995;332:934–40.
3.
GurwitzDKloogY. Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia (letter). JAMA1997;277:1931.
4.
FerrareseC. Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia (response). JAMA1997;277:1931.
5.
DreyerEBLiptonSA. HIV coat protein gp120 stimulates macrophages to release arachidonic acid, which in turn inhibits astrocytic uptake of glutamate (abstract). Neurology1995;45(suppl 4):A420.
6.
LiptonSASucherNJKaiserPKDreyerEB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron1991;7:111–8.
7.
MagnusonDSKnudsenBEGeigerJDBrownstoneRMNathA. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol1995;37:373–80.
8.
LeighPNMeldrumBS. Excitotoxicity in ALS. Neurology1996;47(suppl 4):S221–7.
9.
BensimonGLacomblezLMeiningerV, ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med1994;330:585–91.
10.
LacomblezLBensimonGLeighPNGuilletPMeiningerV, Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet1996;347:1425–31.
11.
DobleA. The pharmacology and mechanism of action of riluzole. Neurology1996;47(suppl 4):S233–41.
SimpsonDMDorfmanDOlneyRKMcKinleyGFDobkinJSoYPeptide T in the treatment of painful distal neuropathy associated with AIDS: Results of a placebo-controlled trial. Neurology1996;47:1254–9.
